Category Medicine and Healthcare
Press Release
Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Advances GelrinC® U.S. pivotal trial with 43 patients treated; Completion of enrollment expected by approximately year end 2026 Expands European commercialization readiness, including surgeon training and regulatory approval of new manufacturing process that improves production yield 400% Strengthened balance sheet with $6.5 million private placement in June 2026 Read More
Press Release
Ahead of 9/11, U.S. Veterans' Non-Profit Partners with World's Only Medically Licensed Ayahuasca Facility to Combat PTSD and Suicide
This private, veteran-only retreat will offer medically supervised plant medicine treatment and long-term integration support for veterans living with treatment-resistant PTSD Read More
Press Release
Sacred Connection Launches Direct-Trade Amazonian Grounding Botanicals in the U.S. to Combat Modern Digital Burnout
Bridging ancestral Amazonian wisdom with modern somatic wellness, Sacred Connection introduces ethically sourced Hapé blends designed to reset overstimulated minds in 60 seconds. Read More
Press Release
The Longevity Centers of America Opens Central Florida Location in Orlando's Dr. Phillips Corridor
The physician-led longevity and regenerative medicine practice is opening its first clinic in the Orlando area and is now accepting patients for the waitlist ahead of its September 28 opening. Read More
Press Release
All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Continuation of treatment with blinded doses of crofelemer in the extension phase of the trial will support company's plans to file an NDA in mid-2027 for MVID, an ultrarare pediatric disease Read More
Press Release
Now Available on Amazon: Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Neonorm® Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool consistency and GI fluid balance in dogs Jaguar expects Neonorm Dog to be available through other select online and animal health retail channels shortly, including Chewy Read More
Press Release
On Labor Day, Guardian Angel AI Turns Attention to America's $1 Trillion Unpaid Workforce: Family Caregivers
As millions of Americans spend the holiday caring for aging parents and loved ones, Guardian Angel AI is building technology designed to make aging at home safer - and caregiving less consuming. Read More
Press Release
Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Jaguar remains sharply focused on its ongoing global development program for oral crofelemer as adjunctive therapy to parenteral support (PS) for pediatric and adult rare IF diseases, including microvillus inclusion disease (MVID) Company plans to file NDA for crofelemer for MVID in mid-2027 to obtain FDA approval Read More
Press Release
HealthJoy Partners with Vālenz Health(R) to Connect Employees to Lower-Cost Procedures and Cancer Care
Bundled Valenz solutions for surgeries, imaging, specialty infusions, and catastrophic care now fully integrated into HealthJoy's Benefits Operating System to drive additional 50%+ savings Read More
Press Release
Lobe Sciences Expands Leadership Team with New CFO Appointment
Dr. David Kideckel, PhD, MBA, joins as Chief Financial Officer, bringing nearly two decades of life sciences, capital markets and corporate advisory experience Current CFO, Mirza Rahimani, transitions to Vice President of Finance, providing continuity across financial reporting and operations Appointment strengthens Lobe's leadership team as the Company advances L-130, its differentiated conjugated psilocin therapeutic being developed at sub-hallucinogenic doses for chronic cluster headache Read More
Press Release
Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Neonorm® Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool consistency and GI fluid balance in dogs Jaguar expects to make Neonorm Dog available through both Amazon and Chewy soon Read More
Press Release
Jaguar Health Reports Second Quarter 2026 Financials
Company remains sharply focused on its ongoing global development program for crofelemer for rare intestinal failure (IF) diseases; as announced, presentation at ESPGHAN 2026 described additional groundbreaking results of evaluation of crofelemer as adjunctive oral therapy for the treatment of pediatric IF, which demonstrate reduction of parenteral support normalized to body weight of up to 48% in patient with the ultrarare microvillus inclusion disease (MVID); company expects clinical package for NDA for MVID to be ready by end of 2026, allowing submission of NDA in Q2 2027 REMINDER: Jaguar to host investor webcast Wednesday, August 19 at 4:30 p.m. Eastern regarding Q2 2026 financials and company updates (click here to register) Read More
Press Release
Imagene AI Joins Proscia Ready Partner Alliance to Advance AI-Powered IHC Companion Diagnostics Development
Integration with Proscia's Concentriq platform will facilitate pharma companies, diagnostic assay and platform providers, and CROs in operationalizing companion diagnostic programs Read More
Press Release
Theralogix Expands Its Women's Health Line with Two Breakthrough NSF-Certified Formulas
Introducing Magnesium L-Theanine Complex™ for relaxation and restorative sleep, and TreBiome™, a full-spectrum pre-, pro-, and postbiotic supporting total microbiome balance and both gut and vaginal health. Read More
Press Release
Paradigm Treatment Receives State Approval to Add Eight Beds at Its Austin Teen Residential Treatment Center
The additional capacity at the Austin, Texas, center responds to sustained demand for adolescent residential mental health care, with the new beds expected to be available in August 2026. Read More
Press Release
Jaguar Health Satisfies Conditions for Receipt of Non-Dilutive $2 Million Holdback Payment from Future Pak for Commercial License to Mytesi and Canalevia-CA1
As announced, Jaguar received an upfront payment of $16M of non-dilutive capital in January 2026 upon entering U.S. license agreement with Future Pak for Mytesi® and Canalevia®-CA1 - Jaguar's two commercialized crofelemer drugs - an agreement that is fully aligned with company's strategy to concentrate crofelemer development efforts on human rare-disease intestinal failure (IF) indications Presentation at ESPGHAN 2026 described additional groundbreaking results of evaluation of crofelemer as adjunctive oral therapy for the treatment of pediatric IF, which demonstrate reduction of parenteral support normalized to body weight of up to 48% in patient with the ultrarare microvillus inclusion disease (MVID) Read More
Press Release
Jaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog
Neonorm® Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool consistency and GI fluid balance in dogs Jaguar expects to make Neonorm Dog available through both Amazon and Chewy Read More
Press Release
Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Jaguar remains sharply focused on its ongoing global development program for oral crofelemer as adjunctive therapy to parenteral support (PS) for rare IF diseases, including MVID Read More
Press Release
Regentis Receives Japanese Patent allowance, Strengthening its Global GelrinC Intellectual Property Portfolio with New Proprietary Manufacturing Technology
Patent expands intellectual property protection in one of the world's largest cartilage repair markets GelrinC is a cell-free hydrogel delivered in a single ~10-minute procedure eliminating the need for cell harvesting, lab processing, and surgeries-potentially setting a new standard of care for knee cartilage repair Read More
Press Release
Imagene AI and Tel Aviv Sourasky University Medical Center (Ichilov) Build Clinical AI Infrastructure to Advance Precision Oncology and Biopharma R&D
The collaboration will enable the development, validation, and application of advanced AI technologies to identify clinically meaningful patient subgroups, support biomarker-driven clinical trials, and create a platform for biopharma partnerships advancing innovation and personalized medicine. Read More
Press Release
